Pathogenesis of type 2 diabetes

Drug Benefit Trends

Volumn 12, Issue SUPPL. A, 2000, Pages 8-16

  Lebovitz, H E ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Hyperglycemia; Insulin resistance; Type 2 diabetes

Indexed keywords

GLUCOSAMINE; GLUCOSE; GLUCOSE TRANSPORTER; INSULIN; INSULIN RECEPTOR; MALONYL COENZYME A; SULFONYLUREA;

BLOOD GLUCOSE MONITORING; CELL FUNCTION; DIABETIC OBESITY; DIET THERAPY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HORMONAL THERAPY; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN METABOLISM; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; REVIEW;

EID: 0033905364     PISSN: 10805826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Diabetes facts and figures (online)
2. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults
3. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: Errors of metabolism or of methods?
4. Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals
5. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome
6. Abdominal adiposity and coronary heart disease in women
7. Association of waist circumference with risk of hypertension and type 2 diabetes in Nigerians, Jamaicans, and African-Americans
8. Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects
9. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity
10. Banting lecture 1990: Beta-cells in type II diabetes mellitus
11. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
12. UK Prospective Diabetes Study, V: Characteristics of newly presenting type 2 diabetic patients: Estimated insulin sensitivity and islet 4-cell function: Multi-centre study
13. Overview of 6 years' therapy of type II diabetes: A progressive disease
14. Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment
15. Acute and chronic effects of hyperglycaemia on glucose metabolism: Implications for the development of new therapies
16. New insights into the metabolic regulation of insulin action and insulin resistance: Role of glucose and amino acids
17. Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?
18. Molecular biology of adenosine triphosphate-sensitive potassium channels
19. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus
20. Type 2 diabetes: An overview
21. UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
22. Metabolic evolution of type 2 diabetes: A 10-year follow-up from the time of diagnosis
23. Insulin-sensitive and insulin-resistant variants in NIDDM